AI assistant
Sending…
Adicet Bio, Inc. — Director's Dealing 2019
Nov 19, 2019
34412_dirs_2019-11-19_0158b543-aa9f-4410-8552-a21938606d6c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: resTORbio, Inc. (TORC)
CIK: 0001720580
Period of Report: 2019-11-15
Reporting Person: PureTech Health LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-15 | Common Stock | S | 531040 | $1.2465 | Disposed | 9269356 | Direct |
Footnotes
F1: Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.43, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
More from Adicet Bio, Inc.
Annual Report
2026
May 20
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Mar 24
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27